Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03313635 · ClinicalTrials.gov registry record
Evaluation of Prealbumin Levels in Men With Low-T
A clinical trial, sponsored by Beckman Coulter.
- Completed
- Registry status
- 19
- Enrollment target
NCT03313635 is a clinical trial that has completed, run by Beckman Coulter. The registered enrollment target is 19 participants.
The verdict
NCT03313635 has completed, sponsored by Beckman Coulter.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
This is a single-center study intended to evaluate prealbumin (transthyretin), a marker of anabolic metabolism, in men with androgen deficiency (Low-T). There is emerging evidence that prealbumin is an indicator of anabolic, versus catabolic, metabolism, and that lower levels may be associated with hypogonadism.
Interventions
- DIAGNOSTIC_TEST Men presenting with low-T
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2017-09-08 |
| Est. Completion | 2017-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03313635
The ClinicalTrials.gov registry entry for NCT03313635 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beckman Coulter, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Men presenting with low-T is the first listed.
NCT03313635 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03313635 about?
NCT03313635 is a clinical study titled "Evaluation of Prealbumin Levels in Men With Low-T". This is a single-center study intended to evaluate prealbumin (transthyretin), a marker of anabolic metabolism, in men with androgen deficiency (Low-T). There is emerging evidence that prealbumin is an indicator of anabolic, versus catabolic, metabolism, and that lower levels may be associated with ...
What is the current status of trial NCT03313635?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2017-09-08. Estimated completion is 2017-12-31.
What interventions are being tested in trial NCT03313635?
The interventions under investigation include: Men presenting with low-T (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03313635?
This trial is sponsored by Beckman Coulter, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.